Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

Clinical trial NCT00239408 · COMPLETED

Trial details

NCT number: NCT00239408
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2002-12-01
Primary completion: 2004-04-01
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.